Jacob Waldrop compensation by year
Sanara MedTech Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $224,337 | $315,000 |
| Bonus | $186,000 | $234,000 |
| Stock awards | $100,007 | $306,244 |
| Option awards | $0 | $0 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $7,875 | $12,600 |
| Total | $518,219 | $867,844 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sanara MedTech Inc. DEF 14A filed April 17, 2026, accession 0001493152-26-017156, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Sanara MedTech Inc. filed document, accession 0001493152-26-017156. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 10,341 | $241,462 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Sanara MedTech Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Sanara MedTech’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Seth Yon | President and Chief Executive Officer | $2,306,511 |
| Jacob Waldrop · this page | Chief Operating Officer | $867,844 |
| Suresh Muppalla | Former President and Chief Executive Officer of Tissue Health Plus, LLC | $715,808 |
| Elizabeth Taylor | Chief Financial Officer | $637,054 |
| Ronald Nixon | Former Chief Executive Officer | $585,479 |
The full Sanara MedTech compensation record
free company briefThis page is one person within Sanara MedTech's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sanara MedTech's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.